[go: up one dir, main page]

AU2003283597A1 - Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors - Google Patents

Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors

Info

Publication number
AU2003283597A1
AU2003283597A1 AU2003283597A AU2003283597A AU2003283597A1 AU 2003283597 A1 AU2003283597 A1 AU 2003283597A1 AU 2003283597 A AU2003283597 A AU 2003283597A AU 2003283597 A AU2003283597 A AU 2003283597A AU 2003283597 A1 AU2003283597 A1 AU 2003283597A1
Authority
AU
Australia
Prior art keywords
benzthiazole
benzoxazole
acid derivatives
heparanase inhibitors
benzimidazole acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003283597A
Other versions
AU2003283597A8 (en
Inventor
Stephen Martin Courtney
Philip Andrew Hay
David Ian Carter Scopes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Glycosciences UK Ltd
Original Assignee
Oxford Glycosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0226820A external-priority patent/GB0226820D0/en
Priority claimed from GB0319542A external-priority patent/GB0319542D0/en
Application filed by Oxford Glycosciences UK Ltd filed Critical Oxford Glycosciences UK Ltd
Publication of AU2003283597A8 publication Critical patent/AU2003283597A8/en
Publication of AU2003283597A1 publication Critical patent/AU2003283597A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57Aryl or substituted aryl radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003283597A 2002-11-16 2003-11-17 Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors Abandoned AU2003283597A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0226820.9 2002-11-16
GB0226820A GB0226820D0 (en) 2002-11-16 2002-11-16 Novel compounds
GB0319542.7 2003-08-20
GB0319542A GB0319542D0 (en) 2003-08-20 2003-08-20 Novel compounds
PCT/GB2003/004991 WO2004046122A2 (en) 2002-11-16 2003-11-17 Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors

Publications (2)

Publication Number Publication Date
AU2003283597A8 AU2003283597A8 (en) 2004-06-15
AU2003283597A1 true AU2003283597A1 (en) 2004-06-15

Family

ID=32328067

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003283597A Abandoned AU2003283597A1 (en) 2002-11-16 2003-11-17 Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors

Country Status (2)

Country Link
AU (1) AU2003283597A1 (en)
WO (1) WO2004046122A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006044502A2 (en) * 2004-10-13 2006-04-27 Ptc Therapeutics, Inc. Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation-related diseases
EP1688413A1 (en) * 2005-02-03 2006-08-09 Hikma Pharmaceuticals Co. Ltd. Benzoxazole derivatives for the prophylaxis and treatment of inflammatory bowel diseases
US20090163476A1 (en) * 2005-03-03 2009-06-25 Sirtris Pharmaceuticals, Inc. N-Phenyl Benzamide Derivatives as Sirtuin Modulators
WO2007042816A1 (en) * 2005-10-12 2007-04-19 Biolipox Ab Benzoxazoles useful in the treatment of inflammation
US8334290B2 (en) 2005-10-31 2012-12-18 Merck Sharp & Dohme Corp. CETP inhibitors
CN101541783B (en) 2006-06-30 2014-10-01 苏尼西斯制药有限公司 pyridinonyl PDK1 inhibitors
JP2010513253A (en) * 2006-12-14 2010-04-30 ベーリンガー インゲルハイム インテルナショナール ゲーエムベーハー Benzoxazoles useful for the treatment of inflammation
EP2118069B1 (en) * 2007-01-09 2014-01-01 Amgen Inc. Bis-aryl amide derivatives useful for the treatment of cancer
JP2012525336A (en) * 2009-04-27 2012-10-22 エラン ファーマシューティカルズ,インコーポレイテッド Alpha-4 integrin pyridinone antagonist
EP2808014A4 (en) 2012-01-27 2016-01-13 Nat Univ Corp Univ Toyama INHIBITOR OF SERINE RACEMASE
CN111018790B (en) 2014-04-29 2023-09-19 Fmc公司 Pyridazinone herbicides
CN104529729B (en) * 2014-12-31 2016-03-30 浙江永太科技股份有限公司 The preparation method of the fluoro-3-chlorobenzaldehyde of a kind of 2-
CA3003419C (en) 2015-10-28 2023-01-24 Thomas Martin Stevenson Novel pyridazinone herbicides
US11787783B2 (en) 2016-12-13 2023-10-17 Beta Therapeutics Pty Ltd Heparanase inhibitors and use thereof
US11718609B2 (en) 2016-12-13 2023-08-08 Beta Therapeutics Pty Ltd Heparanase inhibitors and use thereof
EP3381908A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA 2-(4-(4-(bromo-methoxybenzamido)benzylamino)phenyl)benzazole derivatives and their use as anti-heparanase
EP3381907A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA Symmetrical 2-aminophenyl-benzazolyl-5-acetate compounds and their use as anti-heparanase
TWI785022B (en) 2017-03-28 2022-12-01 美商富曼西公司 Novel pyridazinone herbicides
WO2019018562A1 (en) 2017-07-19 2019-01-24 Ideaya Biosciences, Inc. AMIDO COMPOUNDS AS AhR MODULATORS
CN114760999B (en) 2019-11-18 2024-08-23 外治世拉普提斯株式会社 Composition for treating spinal cord injury comprising stem cells treated with novel compounds
WO2021116820A1 (en) * 2019-12-10 2021-06-17 Aurobindo Pharma Limited An improved process for the preparation of benoxaprofen
CN117924386B (en) * 2023-12-22 2024-07-12 合肥综合性国家科学中心大健康研究院 HPA1 degradation agent and preparation method and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3267081A (en) * 1962-09-19 1966-08-16 Koppers Co Inc Benzothiazole dicarboxylic acids and polymers derived therefrom
GB1435721A (en) * 1972-05-18 1976-05-12 Lilly Industries Ltd Benzoxazole derivatives
JPS4943974A (en) * 1972-09-06 1974-04-25
DE3443594A1 (en) * 1984-11-29 1986-05-28 Bayer Ag, 5090 Leverkusen AMINOPHENYLBENZTHIAZOLE
US4659360A (en) * 1984-11-30 1987-04-21 Fmc Corporation Plant growth and development modification using benzoxazole derivatives
AU2002228317A1 (en) * 2001-01-29 2002-08-12 Insight Strategy And Marketing Ltd Benz-1,3-azole derivatives and their uses as heparanase inhibitors

Also Published As

Publication number Publication date
AU2003283597A8 (en) 2004-06-15
WO2004046122A2 (en) 2004-06-03
WO2004046122A3 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
AU2003283597A1 (en) Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors
TWI350285B (en) N3 alkylated benzimidazole derivatives as mek inhibitors
ZA200501677B (en) Hydantoin derivatives and their use as TACE inhibitors.
IL163996A0 (en) N3 alkylated benzimidazole derivatives as mek inhibitors
IL173935A0 (en) N3 alkylated benzimidazole derivatives as mek inhibitors
SI1701946T1 (en) Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
SG129449A1 (en) Benzimidazole, benzthiazole and benzoxazole derivatives and their use as LTA4H modulators
ZA200410054B (en) Propionic acid derivatives and their use as hPPARsactivators.
AU2002228317A1 (en) Benz-1,3-azole derivatives and their uses as heparanase inhibitors
AU2003302238A1 (en) 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
PL376363A1 (en) Chirale oxazole-arylpropionic acid derivatives and their use as ppar agonists
AU2003249535A1 (en) 1,6-fused uracil derivatives as matrix metalloproteinase inhibitors
AU2003285498A1 (en) Benzoxazole, benzthiazole and benzimidazole derivatives useful as heparanase inhibitors
AU2003258942A1 (en) Imidazolidinedione-derivatives and their use as metalloproteinase inhibitors
AU2003250465A1 (en) 5,6-fused uracil derivatives as matrix metalloproteinase inhibitors
AU2002230056A1 (en) Indole derivatives and their uses as heparanase inhibitors
AU2003277878A1 (en) Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
DK1487802T3 (en) 2,3-diaryl-pyrazolidine derivatives as neurotensin-degrading enzyme inhibitors
AU2003269001A8 (en) Derivatives of uronic (alkyl-d-mannopyranoside) acid, methods for the preparation thereof, and applications thereof
ZA200605302B (en) Use of pentadienoic acid derivatives for the treatment of hyperuricemia
HK1070586A (en) N3 alkylated benzimidazole derivatives as mek inhibitors
HK1077300A (en) Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
HK1070827A (en) Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
HK1072560A (en) Use of thio-oxindole derivatives in treatment of hormone-related conditions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase